Literature DB >> 6832361

Effect of glucose-6-P on the catalytic and structural properties of glycogen phosphorylase a.

A E Melpidou, N G Oikonomakos.   

Abstract

Kinetic studies of muscle phosphorylase a in cationic buffer (pH 6.8) demonstrate that glucose-6-P competitively inhibits the binding of the substrate, glucose-1-P, to the enzyme. The inhibitory effect of glucose-6-P is largely overcome by glycerol-2-P. AMP counteracts inhibition of the enzyme by glucose-6-P, while glucose and glucose-6-P can interact to produce a synergistic inhibition of phosphorylase a activity. Preincubation of phosphorylase a with glucose-6-P at 20 degrees C results in approximately 3-fold increase in activity, while ultracentrifugation experiments carried out under the same conditions showed that phosphorylase a can be converted to dimers by glucose-6-P.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6832361     DOI: 10.1016/0014-5793(83)80884-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  Effects of commonly used cryoprotectants on glycogen phosphorylase activity and structure.

Authors:  K E Tsitsanou; N G Oikonomakos; S E Zographos; V T Skamnaki; M Gregoriou; K A Watson; L N Johnson; G W Fleet
Journal:  Protein Sci       Date:  1999-04       Impact factor: 6.725

2.  Kinetic properties of tetrameric glycogen phosphorylase b in solution and in the crystalline state.

Authors:  D D Leonidas; N G Oikonomakos; A C Papageorgiou; T G Sotiroudis
Journal:  Protein Sci       Date:  1992-09       Impact factor: 6.725

3.  Activator anion binding site in pyridoxal phosphorylase b: the binding of phosphite, phosphate, and fluorophosphate in the crystal.

Authors:  N G Oikonomakos; S E Zographos; K E Tsitsanou; L N Johnson; K R Acharya
Journal:  Protein Sci       Date:  1996-12       Impact factor: 6.725

4.  The structure of a glycogen phosphorylase glucopyranose spirohydantoin complex at 1.8 A resolution and 100 K: the role of the water structure and its contribution to binding.

Authors:  M Gregoriou; M E Noble; K A Watson; E F Garman; T M Krulle; C de la Fuente; G W Fleet; N G Oikonomakos; L N Johnson
Journal:  Protein Sci       Date:  1998-04       Impact factor: 6.725

5.  Allosteric inhibition of glycogen phosphorylase a by the potential antidiabetic drug 3-isopropyl 4-(2-chlorophenyl)-1,4-dihydro-1-ethyl-2-methyl-pyridine-3,5,6-tricarbo xylate.

Authors:  N G Oikonomakos; K E Tsitsanou; S E Zographos; V T Skamnaki; S Goldmann; H Bischoff
Journal:  Protein Sci       Date:  1999-10       Impact factor: 6.725

6.  Sulphate-activated phosphorylase b: the pH-dependence of catalytic activity.

Authors:  S E Zographos; N G Oikonomakos; H B Dixon; W G Griffin; L N Johnson; D D Leonidas
Journal:  Biochem J       Date:  1995-09-01       Impact factor: 3.857

7.  Allosteric interactions of glycogen phosphorylase b. A crystallographic study of glucose 6-phosphate and inorganic phosphate binding to di-imidate-cross-linked phosphorylase b.

Authors:  A Lorek; K S Wilson; M S Sansom; D I Stuart; E A Stura; J A Jenkins; G Zanotti; J Hajdu; L N Johnson
Journal:  Biochem J       Date:  1984-02-15       Impact factor: 3.857

8.  The crystal structure of a phosphorylase kinase peptide substrate complex: kinase substrate recognition.

Authors:  E D Lowe; M E Noble; V T Skamnaki; N G Oikonomakos; D J Owen; L N Johnson
Journal:  EMBO J       Date:  1997-11-17       Impact factor: 11.598

9.  N-acetyl-beta-D-glucopyranosylamine: a potent T-state inhibitor of glycogen phosphorylase. A comparison with alpha-D-glucose.

Authors:  N G Oikonomakos; M Kontou; S E Zographos; K A Watson; L N Johnson; C J Bichard; G W Fleet; K R Acharya
Journal:  Protein Sci       Date:  1995-12       Impact factor: 6.725

10.  The binding of D-gluconohydroximo-1,5-lactone to glycogen phosphorylase. Kinetic, ultracentrifugation and crystallographic studies.

Authors:  A C Papageorgiou; N G Oikonomakos; D D Leonidas; B Bernet; D Beer; A Vasella
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.